Literature DB >> 18976136

Enhancing the nail permeability of topically applied drugs.

Sudaxshina Murdan1.   

Abstract

The topical therapy of nail diseases, especially of onychomycosis, and to a smaller extent, of nail psoriasis, is desirable to avoid the side effects associated with their systemic therapy, to increase patient compliance and reduce the cost of treatment. Systemic therapy is however the mainstay of treatment due to the poor permeability of the nail plate to topically applied drugs. For effective topical therapy, ungual drug permeation must be enhanced. This can be achieved by disrupting the nail plate using physical techniques or chemical agents. Alternatively, drug permeation into the intact nail plate may be encouraged, for example, by iontophoresis or by formulating the drug within a vehicle which enables high drug partition out of the vehicle and into the nail plate. The physical techniques (manual and electrical nail abrasion, acid etching, ablation by lasers, microporation, application of low-frequency ultrasound and electric currents) and chemicals (thiols, sulphites, hydrogen peroxide, urea, water, enzymes) that have shown ungual enhancer activity are discussed in this review. Optimal drug formulation, while crucial to ungual drug delivery, is only briefly reviewed due to the limited literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976136     DOI: 10.1517/17425240802497218

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  15 in total

1.  Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo.

Authors:  M Ghannoum; N Isham; W Henry; H-A Kroon; S Yurdakul
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

2.  An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.

Authors:  Anroop B Nair; Hyun D Kim; Shawn P Davis; Robert Etheredge; Michael Barsness; Phillip M Friden; S Narasimha Murthy
Journal:  Pharm Res       Date:  2009-07-07       Impact factor: 4.200

3.  Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy.

Authors:  Julie Dutet; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2012-08-07       Impact factor: 4.200

4.  Effects of iontophoresis, hydration, and permeation enhancers on human nail plate: infrared and impedance spectroscopy assessment.

Authors:  Ian Benzeval; Christopher R Bowen; Richard H Guy; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2013-03-06       Impact factor: 4.200

5.  Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.

Authors:  Mayur M Patel; Zeal M Vora
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

Review 6.  Essential Oils for Treatment for Onychomycosis: A Mini-Review.

Authors:  Fernanda C Flores; Ruy C R Beck; Cristiane de B da Silva
Journal:  Mycopathologia       Date:  2015-10-19       Impact factor: 2.574

7.  Green nail syndrome treated with the application of tobramycin eye drop.

Authors:  Youin Bae; Gang Mo Lee; Ji Hoon Sim; Sanghoon Lee; Sung Yul Lee; Young Lip Park
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

8.  Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Dharmik M Mehta; Pragna K Shelat
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

Review 9.  Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases.

Authors:  Sudhir Baswan; Gerald B Kasting; S Kevin Li; Randy Wickett; Brian Adams; Sean Eurich; Ryan Schamper
Journal:  Mycoses       Date:  2017-01-18       Impact factor: 4.377

10.  Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Mukesh C Gohel; Pragna K Shelat
Journal:  AAPS PharmSciTech       Date:  2011-12-22       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.